| Patient | Florence Griffith Joyner |
|---|---|
| Date of birth | 1959-12-21 |
| Identifiers | MRN HR-ML033-SYN-TD; SSN (made up) 000-33-2648 |
| Document date | 1996-08-25 |
| Author | Celeste Vanterpool, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Ms. Griffith Joyner is a 36-year-old former Olympic sprinter with focal epilepsy from a left orbitofrontal cavernous malformation, removed completely ten weeks ago, who comes for her yearly preventive visit. She has had no seizure since the one on the flight four and a half months ago. She takes levetiracetam twice a day and folic acid daily and has missed no doses; the early irritability has gone. She is running and doing sprint drills again, swims only with a companion, and wears her seizure detection watch at night. She is not driving. She is not planning a pregnancy in the next year. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 36 |
| Epilepsy | No seizure since the flight; levetiracetam taken as prescribed |
| Surgery | Lesionectomy ten weeks ago; scar healed |
| Mood | PHQ-2 0 |
Health risk assessment. Completed by the patient on the clinic's online form before the visit and reviewed with her by Dr. Vanterpool. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Very good |
| Psychosocial | Busy with design work and youth fitness programs; good supports; some worry about seizures in public, less than before |
| Substance use | No tobacco; alcohol rarely; no drug use |
| Physical activity | Training five or six days a week: running, sprint drills and weights |
| Nutrition | Balanced diet planned around training; folic acid daily |
| Sleep | Seven to eight hours at regular times; detection watch worn at night |
| Safety | Seat belt always as a passenger; not driving; showers rather than baths; swims only with a companion; smoke alarms tested |
| Intimate partner violence | Screened privately with a validated tool: negative |
| Reproductive plans | No pregnancy planned in the next year; contraception reviewed |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss or fatigue |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | No change in smell; no dental problems |
| Cardiovascular | Negative | No chest pain, palpitations or fainting |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No abdominal pain or bowel change |
| Genitourinary | Negative | Regular periods; no abnormal bleeding |
| Breast | Negative | No lump or nipple change |
| Musculoskeletal | Negative | Normal training soreness only |
| Integumentary | Negative | Scalp scar healed; no rash |
| Neurological | Negative | No seizures, spells, headache or weakness |
| Psychiatric | Negative | Mood good; irritability resolved; PHQ-2 0 |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily | One tablet twice daily | Oral route | 1996-05-05 | active | S |
| Folic acid 0.4 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1996-05-05 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day | Two tablets every 6 hours as needed | Oral route | 1996-06-16 to 1996-06-30 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1996-08-25 | Body height | 170 | cm | S |
| 1996-08-25 | Body weight | 60.6 | kg | S |
| 1996-08-25 | Body mass index (BMI) [Ratio] | 21 | kg/m2 | S |
| 1996-08-25 | Systolic blood pressure | 110 | mm[Hg] | S |
| 1996-08-25 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1996-08-25 | Heart rate | 56 | /min | S |
| 1996-08-25 | Respiratory rate | 14 | /min | S |
| 1996-08-25 | Body temperature | 36.6 | Cel | S |
| 1996-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1996-08-25 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 1996-08-25; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Fit and well; weight 60.6 kg; blood pressure 110/70; pulse 56 |
| Head | Left frontal craniotomy scar healed behind the hairline |
| Neck | No thyroid enlargement or lymph nodes |
| Breasts | Clinical breast examination with a chaperone, at her choice: no masses or skin changes |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Abdomen | Soft, non-tender |
| Pelvic | Speculum examination with a chaperone, after she was told each step and agreed: cervix normal; cervical sample taken |
| Skin | No rash or suspicious lesions |
| Neurological | Alert and oriented; cranial nerves, strength, coordination and gait normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Generalized tonic-clonic seizure on a flight two and a half weeks ago, in a 36-year-old woman who was observed overnight in hospital elsewhere and has had treatment for seizures in the past, records requested; no antiseizure medication now; normal examination today. Evaluated as a new seizure: EEG and MRI of the brain with susceptibility-weighted imaging ordered, neurology (epilepsy) review booked, and no driving | resolved | confirmed | R56.9 | S — Synthetic presenting problem anchored to her publicly reported seizure on a flight; superseded by the diagnosis at the epilepsy consultation. |
| Focal epilepsy with structural cause: focal to bilateral tonic-clonic seizure from a left orbitofrontal cavernous malformation, with left frontal epileptiform discharges on EEG; epilepsy under the ILAE 1984 practical definition (an unprovoked seizure with a recurrence risk above 60% from an epileptogenic lesion, and earlier seizures by history); synthetic modern detail linked to her publicly reported seizures and the coroner's finding | active | confirmed | G40.209 | S — Synthetic seizure type, EEG and classification; the seizures and the cavernous angioma of the left orbital frontal cerebrum are documented (D). |
| Solitary cerebral cavernous malformation, 1.4 cm, left orbitofrontal cortex, with a hemosiderin rim and an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging (sporadic pattern); no acute hemorrhage | resolved | confirmed | Q28.3 | S — Synthetic imaging detail; the coroner reported a congenital cavernous angioma of the left orbital frontal cerebrum (D). |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 110/70 mmHg |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 4 five weeks ago |
| Unhealthy alcohol use screening | Completed today | Rare use |
| Tobacco use | Completed today | Never |
| Intimate partner violence screening | Completed today | Screened privately; negative |
| Cervical cancer screening | Completed today | Cytology with HPV co-testing, with a chaperone |
| Breast cancer screening | Not indicated | Mammography from 40 |
| Colorectal cancer screening | Not indicated | Begins at 45 |
| Diabetes screening | Not indicated | Age 36 with a BMI of 21.0 and no risk factor |
| HIV, hepatitis C and hepatitis B screening | Completed today | Once-in-adulthood screening drawn today |
| Folic acid for a woman who could become pregnant | Up to date | 0.4 mg daily, started with levetiracetam |
| Tdap | Completed today | No dose recorded in the past ten years |
| Influenza and COVID-19 vaccines, this season | Due | This autumn, when the season's vaccines arrive |
| Dental and eye examinations | Due | Dental review and an eye examination advised this year |
Immunizations given today: Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) [S]
Guideline basis: Depression and Suicide Risk in Adults: Screening (2023); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Breast Cancer: Screening (2024); Cervical Cancer: Screening (2018); Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults: Screening (2025); Adult Immunization Schedule by Age (2026)
Follow-up: Cervical screening and blood test results by phone. Six-month epilepsy review in October with the driving review. Influenza and COVID-19 vaccines this autumn. Next preventive visit in one year. Next scheduled visit 1996-10-20: six months after the seizure: seizure freedom, driving review, training, and the long-term plan. [S]
Voluntary advance care planning discussion of about 15 minutes, with her consent, after her recent surgery. She wants full treatment for any illness, wants to make her own decisions, and wants information about her health shared only with the people she names. She named a health care agent, recorded in the confidential part of the chart and not named here. She chose not to record other treatment preferences today. To be revisited yearly or if her health changes. [S]